Longitudinal and cross sectional assessments of health utility in adults with HIV/AIDS: a systematic review and meta-analysis

BackgroundUtility estimates are important health outcomes for economic evaluation of care and treatment interventions for patients with HIV/AIDS. We conducted a systematic review and meta-analysis of utility measurements to examine the performance of preference-based instruments, estimate health utility of patients with HIV/AIDS by disease stages, and investigate changes in their health utility over the course of antiretroviral treatment.MethodsWe searched PubMed/Medline, Cochrane Database of Systematic Review, NHS Economic Evaluation Database and Web of Science for English-language peer-reviewed papers published during 2000–2013. We selected 49 studies that used 3 direct and 6 indirect preference based instruments to make a total of 218 utility measurements. Random effect models with robust estimation of standard errors and multivariate fractional polynomial regression were used to obtain the pooled estimates of utility and model their trends.ResultsReliability of direct-preference measures tended to be lower than other types of measures. Utility elicited by two of the indirect preference measures - SF-6D (0.171) and EQ-5D (0.114), and that of Time-Trade off (TTO) (0.151) was significantly different than utility elicited by Standard Gamble (SG). Compared to asymptomatic HIV patients, symptomatic and AIDS patients reported a decrement of 0.025 (p = 0.40) and 0.176 (p = 0.001) in utility scores, adjusting for method of assessment. In longitudinal studies, the pooled health utility of HIV/AIDS patients significantly decreased in the first 3 months of treatment, and rapidly increased afterwards. Magnitude of change varied depending on the method of assessment and length of antiretroviral treatment.ConclusionThe study provides an accumulation of evidence on measurement properties of health utility estimates that can help inform the selection of instruments for future studies. The pooled estimates of health utilities and their trends are useful in economic evaluation and policy modelling of HIV/AIDS treatment strategies.

[1]  A. Wu,et al.  Quality of Life in a Clinical Trial of Highly Active Antiretroviral Therapy Alone or With Intravenous or Subcutaneous Interleukin-2 Administration , 2005, Journal of acquired immune deficiency syndromes.

[2]  Vilija R. Joyce,et al.  Health-Related Quality of Life in a Randomized Trial of Antiretroviral Therapy for Advanced HIV Disease , 2009, Journal of acquired immune deficiency syndromes.

[3]  M. McKenna,et al.  Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008. , 2008, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[4]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[5]  D. Cooper,et al.  A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study , 2000, AIDS.

[6]  M. Norton,et al.  Clinical assessment of symptom-focused health-related quality of life in HIV/AIDS. , 2004, The Journal of the Association of Nurses in AIDS Care : JANAC.

[7]  L. Perestelo-Pérez,et al.  The economic costs and health-related quality of life of people with HIV/AIDS in the Canary Islands, Spain , 2009, BMC health services research.

[8]  L. Lazzeroni,et al.  The Effect of Diagnosis with HIV Infection on Health-Related Quality of Life , 2006, Quality of Life Research.

[9]  Kow-Tong Chen,et al.  Cost-effectiveness of highly active antiretroviral therapy for HIV infection in Taiwan. , 2007, Journal of the Formosan Medical Association = Taiwan yi zhi.

[10]  S. Whitehead,et al.  Health Related Quality of Life among Patients with Tuberculosis and HIV in Thailand , 2012, PloS one.

[11]  J. Jelsma,et al.  The health-related quality of life of people living with HIV/AIDS , 2004, Disability and rehabilitation.

[12]  Vilija R. Joyce,et al.  Quality of Life of Patients With Advanced HIV/AIDS: Measuring the Impact of Both AIDS-Defining Events and Non-AIDS Serious Adverse Events , 2009, Journal of acquired immune deficiency syndromes.

[13]  K. Stavem,et al.  Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS , 2005, Quality of Life Research.

[14]  D. Wild,et al.  A Comparative Review of Health-Related Quality-of-Life Measures for Use in HIV/AIDS Clinical Trials , 2012, PharmacoEconomics.

[15]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[16]  S. Saxena,et al.  WHOQOL-HIV for quality of life assessment among people living with HIV and AIDS: results from the field test. , 2004, AIDS care.

[17]  J. Hornberger,et al.  A Systematic Review of Cost-Utility Analyses in HIV/AIDS: Implications for Public Policy , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

[18]  J. Jelsma,et al.  An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART , 2005, AIDS care.

[19]  B. Tran,et al.  Determinants of health-related quality of life in adults living with HIV in Vietnam , 2011, AIDS care.

[20]  C. Gross,et al.  Health utilities in patients with HIV/AIDS in Thailand. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[21]  T. O. Tengs,et al.  A Meta-Analysis of Utility Estimates for HIV/AIDS , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.

[22]  N. Bansback,et al.  Impact of the recall period on measuring health utilities for acute events. , 2008, Health economics.

[23]  Milo A Puhan,et al.  Interviewer versus self-administered health-related quality of life questionnaires - Does it matter? , 2011, Health and quality of life outcomes.

[24]  A. Wu,et al.  The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy. , 2003, Ophthalmology.

[25]  P. Garvie,et al.  Quality of life measurement in paediatric and adolescent populations with HIV: a review of the literature. , 2009, Child: care, health and development.

[26]  B. Tran,et al.  Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients , 2012, Health and Quality of Life Outcomes.

[27]  Milton C Weinstein,et al.  Comparison of Health State Utilities Using Community and Patient Preference Weights Derived from a Survey of Patients with HIV/AIDS , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.

[28]  W. Mathews,et al.  EuroQol (EQ-5D) measure of quality of life predicts mortality, emergency department utilization, and hospital discharge rates in HIV-infected adults under care , 2007, Health and quality of life outcomes.

[29]  M. Humbert,et al.  Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension. , 2004, American journal of respiratory and critical care medicine.

[30]  Vilija R. Joyce,et al.  Effect of Treatment Interruption and Intensification of Antiretroviral Therapy on Health-Related Quality of Life in Patients with Advanced HIV , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

[31]  M. Manns,et al.  Differential influence of different hepatitis viruses on quality of life in HIV positive patients. , 2006, European journal of medical research.

[32]  Tsuguya Fukui,et al.  Utilities Measured by Rating Scale, Time Trade-off, and Standard Gamble: Review and Reference for Health Care Professionals , 2002, Journal of epidemiology.

[33]  M. Barry,et al.  Health-related quality of life of HIV-infected intravenous drug users , 2013, International journal of STD & AIDS.

[34]  S. Hammer,et al.  Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  P. Vanhems,et al.  Quality of life assessment and HIV infection: A review , 1996, European Journal of Epidemiology.

[36]  A. Wu,et al.  Quality of life and HIV: current assessment tools and future directions for clinical practice. , 2003, The AIDS reader.

[37]  T. Delate,et al.  The use of 2 health-related quality-of-life measures in a sample of persons infected with human immunodeficiency virus. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  K. Govender,et al.  A comparison of quality of life between HIV positive and negative diamond miners in South Africa , 2013, SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance.

[39]  V. Joish,et al.  Cost-utility analysis and quality adjusted life years. , 2005, Journal of pain & palliative care pharmacotherapy.

[40]  A. Wu,et al.  Validity and responsiveness of the EuroQol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial , 2002, Quality of Life Research.

[41]  M. Sprangers,et al.  Health-Related Quality-of-Life Evaluation in HIV-Infected Patients , 1995, PharmacoEconomics.

[42]  Marten Postma,et al.  The societal burden of HIV/AIDS in Northern Italy: An analysis of costs and quality of life , 2008, AIDS care.

[43]  A. Bhargava,et al.  Healthcare infrastructure and emotional support are predictors of CD4 cell counts and quality of life indices of patients on antiretroviral treatment in Free State Province, South Africa , 2010, AIDS care.

[44]  S. Rourke,et al.  Prediction of Health Preference Values from CD4 Counts in Individuals with HIV , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.

[45]  A. Leonard,et al.  Health Values of Patients Coinfected With HIV/Hepatitis C: Are Two Viruses Worse Than One? , 2006, Medical care.

[46]  P. Serrano-Aguilar,et al.  Health related quality of life of Canary Island citizens , 2010, BMC public health.

[47]  Joel Tsevat,et al.  The Will To Live among HIV-Infected Patients , 1999, Annals of Internal Medicine.

[48]  F. Lampe,et al.  What factors are associated with patient self-reported health status among HIV outpatients? A multi-centre UK study of biomedical and psychosocial factors , 2012, AIDS care.

[49]  Vilija R. Joyce,et al.  The concurrent validity and responsiveness of the health utilities index (HUI 3) among patients with advanced HIV/AIDS , 2009, Quality of Life Research.

[50]  A. Wu,et al.  Quality of life assessment comes of age in the era of highly active antiretroviral therapy. , 2000, AIDS.

[51]  Sophia Rabe-Hesketh,et al.  Multilevel and Longitudinal Modeling Using Stata , 2005 .

[52]  A Mocroft,et al.  Health-Related Quality of Life in Individuals Infected with HIV in the Era of HAART , 2001, HIV clinical trials.

[53]  A. Haycox,et al.  Utility assessment of HIV/AIDS-related health states in HIV-infected Ugandans , 2008, AIDS.

[54]  A. Leonard,et al.  Health-related quality of life in veterans and nonveterans with HIV/AIDS , 2006, Journal of General Internal Medicine.

[55]  A. Lazzarin,et al.  Number of daily pills, dosing schedule, self‐reported adherence and health status in 2010: a large cross‐sectional study of HIV‐infected patients on antiretroviral therapy , 2013, HIV Medicine.

[56]  F Patrick Robinson.  Measurement of quality of life in HIV disease. , 2004, The Journal of the Association of Nurses in AIDS Care : JANAC.

[57]  A. Wu,et al.  The Impact of Episodic CD4 Cell Count-Guided Antiretroviral Therapy on Quality of Life , 2008, Journal of acquired immune deficiency syndromes.

[58]  D. Feeny,et al.  A utility approach to the assessment of health-related quality of life. , 2000, Medical care.

[59]  S. Ettner,et al.  Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders. , 2009, The journal of mental health policy and economics.

[60]  R. Chaisson,et al.  Quality of life among people treated for tuberculosis and human immunodeficiency virus in Rio de Janeiro, Brazil. , 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[61]  S. Raudenbush,et al.  A multivariate mixed linear model for meta-analysis. , 1996 .

[62]  D. Neuhauser,et al.  Feasibility, reliability and validity of health-related quality of life questionnaire among adult pulmonary tuberculosis patients in urban Uganda: cross-sectional study , 2010, Health and quality of life outcomes.

[63]  Leslie A Lenert,et al.  Adverse effects of medications and trade-offs between length of life and quality of life in human immunodeficiency virus infection. , 2002, The American journal of medicine.

[64]  K. Wyrwich,et al.  Health utility measures and the standard gamble. , 2003, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[65]  M. Manns,et al.  GB virus C infection and quality of life in HIV-positive patients , 2004, AIDS care.

[66]  L Goldman,et al.  Stability of Time-tradeoff Utilities in Survivors of Myocardial Infarction , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[67]  M. Jensen,et al.  The burden of neuropathic pain: A systematic review and meta-analysis of health utilities , 2010, PAIN®.

[68]  A. Wu,et al.  US and UK versions of the EQ-5D preference weights: Does choice of preference weights make a difference? , 2007, Quality of Life Research.

[69]  A. Wu,et al.  Incorporating quality of life measures in HIV clinical trials , 2002, HIV clinical trials.

[70]  Stacey L. Farber,et al.  Patterns of responses on health-related quality of life questionnaires among patients with HIV/AIDS , 2006, Journal of General Internal Medicine.

[71]  J. Kaldor,et al.  Cognitive function, mood and health‐related quality of life in hepatitis C virus (HCV)‐monoinfected and HIV/HCV‐coinfected individuals commencing HCV treatment * , 2007, HIV medicine.

[72]  M. Bachmann,et al.  Highly active antiretroviral treatment and health related quality of life in South African adults with human immunodeficiency virus infection: A cross-sectional analytical study , 2007, BMC public health.

[73]  J. Oliva,et al.  Indirect costs in ambulatory patients with HIV/AIDS in Spain , 2012, PharmacoEconomics.

[74]  B. Aranda-Naranjo.  Quality of life in the HIV-positive patient: implications and consequences. , 2004, The Journal of the Association of Nurses in AIDS Care : JANAC.

[75]  B. Stilwell,et al.  Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006 revision. , 2006 .